BNTX
BioNTech SE
NASDAQ · Healthcare · Biotechnology · DE
$90.70
+4.35%Margins
Gross margin
69.9%
EBITDA margin
-21.9%
EBIT margin
-71.5%
Net margin
-61.3%
FCF margin
-18.9%
-8.4%
Return on equity
-7.3%
Return on assets
-9.5%
Return on invested capital
0.12x
Asset turnover
-$277.0M
Cash from operations
$45
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026